Snapshot · Elevance Health Inc. (ELV)

Data as of 2026-10-18T09:46:39.754Z

Fundamentals check

Market cap

$92.9B

P/E (TTM)

19.0

Gross margin

39.0%

Net margin

2.5%

ROE

11.2%

R&D / revenue

0.0%

Dividend yield

1.6%

FCF yield

6.8%

Latest dividend: $1.72/share (ex-date 2026-09-10, quarterly)

Summary

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

How it makes money

Revenue mix, latest fiscal year

• Health Benefits Segment70%
• Carelon Services Segment30%

Recent Events

• 2026-10-16T10:21:01.000Zneutral

  Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics

  可能与Q3展望相关，聚焦关键指标预测，需结合实际披露判断影响力度。

  Source: zacks.com

• 2026-10-15T13:31:00.000Znegative

  Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?

  可能与Q3盈利前景相关，指出保费下降和经营利润波动等挑战，尚需后续结果确认因果关系。

  Source: Zacks Investment Research

• 2026-10-10T02:58:58.000Zneutral

  biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review

  可能与ELV在行业对比中的定位相关，提供对比视角，但不构成因果断言。

  Source: defenseworld.net

• 2026-10-05T12:41:03.000Zneutral

  ELV or DHR: Which Is the Better Value Stock Right Now?

  可能与价值评估相关，比较ELV与DHR的估值与前景，属于分析性对比，非因果断言。

  Source: zacks.com

• 2026-10-02T10:40:50.000Zneutral

  Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?

  可能与ELV今年相对表现相关，提示与行业对比的趋势，但不足以确认因果关系。

  Source: zacks.com

• 2026-10-01T07:00:00.000Zpositive

  Elevance Health's Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support

  可能与2027年Medicare优势计划相关，反映产品与服务扩展对前景的潜在正面影响，但需进一步披露确认因果关系。

  Source: businesswire.com

• 2026-09-10T00:00:00.000Zpositive

  Price move: ELV rose 4.9%

  ELV 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-08-05T00:00:00.000Zpositive

  Price move: ELV rose 3.5%

  ELV 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $464.5 from 2 analysts (last quarter)

Insider & Congress activity

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。